Scinai Immunotherapeutics Ltd. (SCNI)
1.72
+0.02
(+1.18%)
USD |
NASDAQ |
Sep 09, 16:00
1.72
0.00 (0.00%)
After-Hours: 19:07
Scinai Immunotherapeutics Enterprise Value : 7.323M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 7.323M |
| September 04, 2026 | 7.414M |
| September 03, 2026 | 7.466M |
| September 02, 2026 | 7.688M |
| September 01, 2026 | 7.756M |
| August 31, 2026 | 7.779M |
| August 28, 2026 | 7.785M |
| August 27, 2026 | 7.882M |
| August 26, 2026 | 7.990M |
| August 25, 2026 | 7.996M |
| August 24, 2026 | 8.138M |
| August 21, 2026 | 8.189M |
| August 20, 2026 | 8.030M |
| August 19, 2026 | 7.916M |
| August 18, 2026 | 7.696M |
| August 17, 2026 | 7.655M |
| August 14, 2026 | 7.736M |
| August 13, 2026 | 7.722M |
| August 12, 2026 | 7.762M |
| August 11, 2026 | 7.699M |
| August 10, 2026 | 7.786M |
| August 07, 2026 | 7.752M |
| August 06, 2026 | 7.829M |
| August 05, 2026 | 7.779M |
| August 04, 2026 | 7.780M |
| Date | Value |
|---|---|
| August 03, 2026 | 7.910M |
| July 31, 2026 | 7.910M |
| July 30, 2026 | 7.927M |
| July 29, 2026 | 7.874M |
| July 28, 2026 | 7.859M |
| July 27, 2026 | 7.761M |
| July 24, 2026 | 7.665M |
| July 23, 2026 | 7.762M |
| July 22, 2026 | 7.797M |
| July 21, 2026 | 7.754M |
| July 20, 2026 | 7.751M |
| July 17, 2026 | 7.778M |
| July 16, 2026 | 7.802M |
| July 15, 2026 | 7.853M |
| July 14, 2026 | 7.729M |
| July 13, 2026 | 7.728M |
| July 10, 2026 | 7.783M |
| July 09, 2026 | 7.825M |
| July 08, 2026 | 7.893M |
| July 07, 2026 | 7.824M |
| July 06, 2026 | 7.886M |
| July 02, 2026 | 7.895M |
| July 01, 2026 | 7.904M |
| June 30, 2026 | 7.794M |
| June 29, 2026 | 6.104M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Compugen Ltd. | 120.22M |
| Pluri, Inc. | 42.93M |
| Evogene Ltd. | 8.679M |
| CollPlant Biotechnologies Ltd. | 49.66M |
| Regentis Biomaterials Ltd. | 52.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.037M |
| Revenue (Quarterly) | 0.4679M |
| Total Expenses (Quarterly) | 2.505M |
| EPS Diluted (Quarterly) | -3.662 |
| Gross Profit Margin (Quarterly) | -272.2% |
| Profit Margin (Quarterly) | -435.4% |
| Earnings Yield | -25.73K% |
| Normalized Earnings Yield | -12659.60 |